연구동향 분석

중심망막정맥폐쇄의 장기 결과와 황반부종 소실과 연관된 인자

송미연 김종우 김철구 김재휘 2022년

논문상세정보
인용/피인용
' 중심망막정맥폐쇄의 장기 결과와 황반부종 소실과 연관된 인자' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Prognosis
  • macular edema
  • retinal vein occlusion
  • subretinalfluid
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
725 0

0.0%

' 중심망막정맥폐쇄의 장기 결과와 황반부종 소실과 연관된 인자' 의 참고문헌

  • 중심망막정맥폐쇄에서 베바시주맙군과 저용량 베바시주맙-트리암시놀론 혼합군의 단기 효과 비교
    김병재 [2016]
  • 망막중심정맥폐쇄에서 유리체강내 베바시주맙 주사 전 후에 망막전위도를 통한 망막기능의 평가
    조인환 [2011]
  • 망막중심정맥폐쇄에서 발생한 황반부종에 대한 유리체강내 베바시주맙 주입술의 효과
    최성욱 [2010]
  • 망막분지정맥폐쇄환자에서 빛간섭단층계를 이용한 황반부종의 형태학적 관찰
    이승우 [2005]
  • Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion : six-month results of the phase 3 COPERNICUS study
    Boyer D [2012]
  • Twelve-year incidence of retinal vein occlusion and its trend in Korea
    Park JY [2020]
  • The Central Retinal Vein Bypass Study : a trial of laser-induced chorioretinal venous anastomosis for central retinal vein occlusion
  • Retinal vascular occlusions
    Scott IU [2020]
  • Ranibizumab for retinal vein occlusion : predictive factors and long-term outcomes in real-life data
  • Ranibizumab for macular edema following central retinal vein occlusion : six-month primary end point results of a phase III study
    Brown DM [2010]
  • Predictors of neovascular glaucoma in central retinal vein occlusion
    Rong AJ [2019]
  • Pharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept(vascular endothelial growth factor Trap-eye)
    Stewart MW [2012]
  • Natural history of visual outcome in central retinal vein occlusion
    Hayreh SS [2011]
  • Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group
    [1997]
  • Macular edema secondary to retinal vein occlusion in a real-life setting : a multicenter, nationwide, 3-year follow-up study
    Costa JV [2021]
  • Long-term safety and efficacy of intravitreal bevacizumab(Avastin)for the management of central retinal vein occlusion
    Gregori NZ [2008]
  • Induction of retinochoroidal venous anastomosis in central retinal vein occlusion with macular edema via a full-thickness retinochoroidal incision
    Kang JH [2008]
  • Glaucoma as a prognostic factor of central retinal vein occlusion : visual and anatomical outcomes and occurrence of ischaemic central retinal vein occlusion
    Kim YN [2021]
  • Efficacy and safety of intravitreal aflibercept treat-and-extend for macular edema in central retinal vein occlusion : the CENTERA Study
  • Disease-modifying effects of ranibizumab for central retinal vein occlusion
    Huang JM [2022]
  • Different factors associated with 2-year outcomes in patients with branch versus central retinal vein occlusion treated with ranibizumab
    Sophie R [2019]
  • Clinical significance of subclinical atherosclerosis in retinal vein occlusion
    Lyu M [2021]
  • Baseline factors associated with 6-month visual acuity and retinal thickness outcomes in patients with macular edema secondary to central retinal vein occlusion or hemiretinal vein occlusion : SCORE2 Study Report 4
    Scott IU [2017]
  • Anxiety and pain perception using a speculum-free eyelid retraction technique for intravitreal injection
    Wasser LM [2022]
  • 2015년 한국망막학회 회원의 유리체 망막 질환에 대한 설문 조사: 유리체 망막 질환 진료와 치료의 최근 경향
    이주용 [2016]